A multidisciplinary team intervenes at each stage of the care pathway. The Prostate Centre ensures coordinated care for stakeholders and involves the patient at every stage of decision-making. The patient can at any time ask questions, reconsider his choice or ask for a time of reflection.
Announcement of the diagnosis
In general, following the PSA assay by the attending physician, the patient is required to consult a urologist. The diagnosis is made on the basis of the various investigations carried out (palpation, imaging, biopsies, etc.) which depend on the type of cancer.
Announcement of the diagnosis Multidisciplinary colloquium
Once the diagnosis is confirmed, the urologist presents the patient's file at a multidisciplinary symposium also called "tumoboard". Doctors specializing in urology, oncology, radiotherapy, radiation oncology, radiology, pathology, nuclear medicine as well as the clinical nurse specialist discuss the situation and jointly develop a proposal for a therapeutic strategy.
Information and processing
The choice of appropriate treatment depends on the stage of the disease, the age and general condition of the patient, as well as his wishes. The treatment options available today are very broad. The multidisciplinary colloquium gives the patient the assurance of obtaining the most appropriate treatment for his situation. The treatment decision requires detailed interviews with the patient and his relatives.
Monitoring progress
Once the patient has benefited from the planned treatment , he is regularly monitored by specialists, who may use different examinations (PSA assay, imaging, etc.) to control the disease and its progression. They also ensure the management of any side effects following the treatment.
Route de Chêne 112 - Batiment A
1224 Chêne-Bougeries